{{ (moduleVm.actions && moduleVm.changeStatus) ? moduleVm.status : '' }} The Treatment of Migraine Headache in the Presence of Selective Serotonin Reuptake Use: Pharmacokinetic Considerations

Purpose of Activity

To provide information about the pharmacokinetic considerations with treatment of migraine headache in the presence of SSRI use.

Learning Objectives/Outcomes

After completing this continuing education activity you will be able to:

  1. Describe the pharmacokinetic considerations of triptan medication use for treatment of migraine headaches with co-morbid treatment of depression using selective serotonin reuptake inhibitors (SSRIs).
  2. Identify signs/symptoms of serotonin syndrome and management of patients with serotonin syndrome and severe toxicity.
Price: $21.95

Credits:

  • ANCC 2.0 CH
  • DC - BON 2.0 CH
  • FL - BON 2.0 CH

Lippincott Williams & Wilkins is accredited as a provider of continuing nursing education by the American Nurses Credentialing Center's Commission on Accreditation.
--------------------------------------------------
This activity is also provider approved by the California Board of Registered Nursing, Provider Number CEP 11749. Lippincott Williams & Wilkins is also an approved provider of continuing nursing education by the District of Columbia and Florida #50-1223. Your certificate is valid in all states.





Test Code: JNN0715
Published: Aug 2015
Expires: 6/4/2021
Passing Score: 13/18 (72%)
Authors: Alyssa Liguori Macca, DNP, ARNP-BC
Specialties: Neurology, Pain Management